Advertisement

The Role of B Cells in Mouse Hepatitis Virus Infection and Pathology

  • Amy E. Matthews
  • Susan R. Weiss
  • Ehud Lavi
  • Mark Shlomchik
  • Yvonne Paterson
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 494)

Abstract

Murine hepatitis virus (MHV) strain A59 infects the central nervous system (CNS) and liver of mice, causing encephalitis and hepatitis. Virus is cleared from both organs by 16 days post-infection (dpi) (Lavi et al, 1986; data not shown). Infection of the CNS by this virus is associated with demyelination. Interestingly, demyelination peaks at around 30 dpi, after infectious virus is cleared and only viral RNA and small amounts of protein remain (Lavi et al, 1984a, 1984b; Sutherland et al, 1997; data not shown).

Keywords

Viral Titer Infectious Virus Viral Clearance Wildtype Mouse Mouse Hepatitis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Chan O. T., Hannum L. G., Haberman A. M., Madaio M. P., and Shlomchik M. J., 1999, A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med. 189:1639–1648.PubMedCrossRefGoogle Scholar
  2. Circolo A, Gamier G., Fukuda W., Wang X., Hidvegi T., Szalai A. J., Briles D. E., Volanakis J. E., Wetsel R. A., and Colten H. R., 1999, Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology. 42:135–149.PubMedCrossRefGoogle Scholar
  3. Constant, S., Schweitzer, N., West, J., Ranney, P., and Bottomry, K., 1995, B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J. lmm. 155:3734–3741.Google Scholar
  4. Gombold, J. L., Hingley, S. T., and Weiss, S. R., 1993, Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4505–4512.Google Scholar
  5. Gombold, J. L., Sutherland, R. M., Lavi, E., Paterson, Y., and Weiss, S. R., 1995, Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microbial Pathogenesis. 18:211–221.PubMedCrossRefGoogle Scholar
  6. Houtman, J. J., and Fleming, J. O., 1996, Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine Coronavirus JHM. J. Neuro Virology. 2:101–110.Google Scholar
  7. Lavi, E., Gilden, D. H., Wroblewska, Z., Rorke, L. B., and Weiss, S. R., 1984a, Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 34:597–603.PubMedCrossRefGoogle Scholar
  8. Lavi, E., Gilden, D. H., Wroblewska, Z., Rorke, L. B., and Weiss, S. R., 1984b, Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infectionin mice as detected by in situ hybridization. J. Virol. 51:563–566.PubMedGoogle Scholar
  9. Lavi, E., Gilden, D. H., Highkin, M. K., and Weiss, S. R., 1986, The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab. Animal Sci. 36:130–135.Google Scholar
  10. Phillips, J. A., Romball, C. G., Hobbs, M. V., Ernst, D. N., Shultz, L., and Weigle, W. O., 1996, CD4+ T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183:1339–1344.PubMedCrossRefGoogle Scholar
  11. Sutherland, R. M., Chua, M-M, Lavi, E., Weiss, S. R., and Paterson, Y., 1997, CD4+ and CD8+ cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J. Neurovirology. 3:225–228.CrossRefGoogle Scholar
  12. Wang, F., Stohlman, S. A., and Fleming, J. O., 1990, Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 30:31–41.PubMedCrossRefGoogle Scholar
  13. Williamson, J. S. P. and Stohlman, S. A., 1990, Effective clearance of murine hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol. 64:4589–4592.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Amy E. Matthews
    • 1
  • Susan R. Weiss
    • 1
  • Ehud Lavi
    • 2
  • Mark Shlomchik
    • 3
  • Yvonne Paterson
    • 1
  1. 1.Department of MicrobiologyUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of PathologyUniversity of PennsylvaniaPhiladelphiaUSA
  3. 3.Department of Laboratory Medicine and Section of ImmunobiologySchool of Medicine, Yale UniversityNew HavenUSA

Personalised recommendations